SAN DIEGO--(BUSINESS WIRE)--Metabasis Therapeutics, Inc. (Nasdaq: MBRX), a biopharmaceutical company focused on the clinical development of innovative therapies to treat metabolic diseases such as hyperlipidemia and diabetes, today announced the appointment of Tran B. Nguyen as Vice President and Chief Financial Officer.
